Global Human Oocyte Cryopreservation Supply, Demand and Key Producers, 2026-2032
Description
The global Human Oocyte Cryopreservation market size is expected to reach $ 274 million by 2032, rising at a market growth of 14.6% CAGR during the forecast period (2026-2032).
Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.
Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196°C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.
The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress
The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.
Changes in fertility concepts
The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.
Growth in medical demand
With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.
Policy support
The support policies of some countries and regions for assisted reproductive technology, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.
Unlike sperm, oocytes are larger and contain a lot of water, which makes it easier to form ice crystals that may damage the eggs during the freezing process. In addition, egg extraction is not easy and the number is scarce, so the selection of protective agents during the freezing process is also more demanding. These factors have made egg freezing one of the difficulties in freezing technology.
However, with the continuous advancement of technology, the success rate of oocyte cryopreservation has been significantly improved. International clinical trials have proven that frozen eggs can be stored for at least ten years, and they still have the ability to conceive after thawing, can form healthy embryos, and can normally conceive babies. This has led more and more women to choose to preserve their future reproductive ability through oocyte cryopreservation technology, that is, to buy a "fertility insurance".
In general, oocyte cryopreservation technology provides an effective option for women who want to preserve their fertility, and also provides new possibilities for the development of assisted reproductive technology.
This report studies the global Human Oocyte Cryopreservation demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Oocyte Cryopreservation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Oocyte Cryopreservation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Oocyte Cryopreservation total market, 2021-2032, (USD Million)
Global Human Oocyte Cryopreservation total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Human Oocyte Cryopreservation total market, key domestic companies, and share, (USD Million)
Global Human Oocyte Cryopreservation revenue by player, revenue and market share 2021-2026, (USD Million)
Global Human Oocyte Cryopreservation total market by Type, CAGR, 2021-2032, (USD Million)
Global Human Oocyte Cryopreservation total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Human Oocyte Cryopreservation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anova Fertility, CCRM IVF, Chill, CREATE Fertility, Extend Fertility, HRC Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Human Oocyte Cryopreservation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Oocyte Cryopreservation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Human Oocyte Cryopreservation Market, Segmentation by Type:
Slow-cooling Method
Flash-freezing Process (Vitrification)
Global Human Oocyte Cryopreservation Market, Segmentation by Application:
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Companies Profiled:
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility
Key Questions Answered
1. How big is the global Human Oocyte Cryopreservation market?
2. What is the demand of the global Human Oocyte Cryopreservation market?
3. What is the year over year growth of the global Human Oocyte Cryopreservation market?
4. What is the total value of the global Human Oocyte Cryopreservation market?
5. Who are the Major Players in the global Human Oocyte Cryopreservation market?
6. What are the growth factors driving the market demand?
Human oocyte cryopreservation (egg freezing) is a procedure to preserve female eggs (oocytes). The eggs are extracted, frozen and stored. The purpose of the procedure is to give women the option of thawing, fertilizing and transplanting the eggs into the uterus as embryos to promote future pregnancy.
Oocyte cryopreservation refers to the technology of cooling human oocytes and storing them in liquid nitrogen (generally stored in liquid nitrogen at -196°C), resuscitating (thawing) them when needed, and ensuring that the oocytes are alive and functioning normally. It is a derivative technology of assisted reproductive technology, mainly used to treat infertility and preserve female fertility.
The driving factors of the oocyte cryopreservation market mainly include the following aspects:
Technological progress
The continuous improvement and maturity of oocyte cryopreservation technology has improved the recovery rate and survival rate of frozen oocytes, thereby increasing the clinical application prospects of this technology and driving the development of the market.
Changes in fertility concepts
The changes in modern women's fertility concepts and the intensification of the trend of late marriage and late childbearing have led more and more women to choose oocyte cryopreservation technology to maintain fertility and provide guarantees for future fertility plans.
Growth in medical demand
With the improvement of medical standards and people's attention to reproductive health, more and more medical institutions and patients have begun to pay attention to oocyte cryopreservation technology, which has promoted the rapid development of the market.
Policy support
The support policies of some countries and regions for assisted reproductive technology, as well as the improvement of relevant laws and regulations, have provided a good policy environment for the development of oocyte cryopreservation technology.
Unlike sperm, oocytes are larger and contain a lot of water, which makes it easier to form ice crystals that may damage the eggs during the freezing process. In addition, egg extraction is not easy and the number is scarce, so the selection of protective agents during the freezing process is also more demanding. These factors have made egg freezing one of the difficulties in freezing technology.
However, with the continuous advancement of technology, the success rate of oocyte cryopreservation has been significantly improved. International clinical trials have proven that frozen eggs can be stored for at least ten years, and they still have the ability to conceive after thawing, can form healthy embryos, and can normally conceive babies. This has led more and more women to choose to preserve their future reproductive ability through oocyte cryopreservation technology, that is, to buy a "fertility insurance".
In general, oocyte cryopreservation technology provides an effective option for women who want to preserve their fertility, and also provides new possibilities for the development of assisted reproductive technology.
This report studies the global Human Oocyte Cryopreservation demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Human Oocyte Cryopreservation, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Human Oocyte Cryopreservation that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Human Oocyte Cryopreservation total market, 2021-2032, (USD Million)
Global Human Oocyte Cryopreservation total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Human Oocyte Cryopreservation total market, key domestic companies, and share, (USD Million)
Global Human Oocyte Cryopreservation revenue by player, revenue and market share 2021-2026, (USD Million)
Global Human Oocyte Cryopreservation total market by Type, CAGR, 2021-2032, (USD Million)
Global Human Oocyte Cryopreservation total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Human Oocyte Cryopreservation market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Anova Fertility, CCRM IVF, Chill, CREATE Fertility, Extend Fertility, HRC Fertility, IVF Australia, Kindbody, London Women’s Clinic, Manchester Fertility, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Human Oocyte Cryopreservation market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Human Oocyte Cryopreservation Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Human Oocyte Cryopreservation Market, Segmentation by Type:
Slow-cooling Method
Flash-freezing Process (Vitrification)
Global Human Oocyte Cryopreservation Market, Segmentation by Application:
25-30 Year Old Female
30-35 Year Old Female
35-40 Year Old Female
Others
Companies Profiled:
Anova Fertility
CCRM IVF
Chill
CREATE Fertility
Extend Fertility
HRC Fertility
IVF Australia
Kindbody
London Women’s Clinic
Manchester Fertility
Mayo Clinic
Melbourne IVF
Monash IVF
Pacific Fertility Center-Los Angeles (PFCLA)
PIVET
Prelude Fertility
Key Questions Answered
1. How big is the global Human Oocyte Cryopreservation market?
2. What is the demand of the global Human Oocyte Cryopreservation market?
3. What is the year over year growth of the global Human Oocyte Cryopreservation market?
4. What is the total value of the global Human Oocyte Cryopreservation market?
5. Who are the Major Players in the global Human Oocyte Cryopreservation market?
6. What are the growth factors driving the market demand?
Table of Contents
148 Pages
- 1 Supply Summary
- 2 Demand Summary
- 3 World Human Oocyte Cryopreservation Companies Competitive Analysis
- 4 United States VS China VS Rest of World (by Headquarter Location)
- 5 Market Analysis by Type
- 6 Market Analysis by Application
- 7 Company Profiles
- 8 Industry Chain Analysis
- 9 Research Findings and Conclusion
- 10 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
